DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression, Genotyping), By End-user, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global DNA microarray market size was valued at USD 1,835.54 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2030. The rising prevalence of cancer, the rapidly evolving information & software technology, and emerging bioinformatics are the factors likely to drive the global DNA microarray market. In addition, the surge in research activities and the rising use of DNA microarray in gene expression fuel the global market growth.

For instance, in January 2023, the NCBI announced the development of a microarray system to detect UDP-glucuronosyltransferase gene polymorphisms for use in clinical laboratories in patients eligible for irinotecan hydrochloride treatment. It allows the construction of a measurement system for high-density and DNA fixation clinical applications.

The rising burden of cancer is anticipated to provide momentum for market growth, as recent studies have demonstrated the efficacy of DNA microarray in determining primary sites in metastatic cancers and the classification of soft tissue sarcomas. According to estimates by the Canadian Cancer Society, the country reported 233,900 new cancer cases with 85,100 deaths.

The leading cancers in Canada are breast, prostate, lung, and colorectal cancer. Moreover, increasing use of the technology in the discovery of disease-related genes and diagnosis using its biomarkers are anticipated to create new market opportunities during the forecast period.

Moreover, strategic initiatives undertaken by the key players include partnerships & collaborations to strengthen precision medicine and genotyping capabilities, which are expected to offer lucrative growth opportunities for the market. For instance, in May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar. This partnership expanded the advantages of precision medicine across the Middle East. Moreover, it comprises custom genotyping arrays designed to boost clinical applications of predictive genomics.

DNA microarray has a wide range of applications in gene expression, genotyping, and transcription studies. Gene expression became a leading technology used in various applications like clinical diagnostics, microbiology, and drug discovery & development procedures. The application of this technique across different steps of the drug discovery process has increased in past years. Limitations in adopting conventional technologies, along with leveraging applications of DNA microarray in genotyping and gene expression, have boosted the development of novel approaches.

Increasing penetration of DNA microarray technology in R&D activities is anticipated to drive market growth for different end-users such as research institutes and pharmaceutical & biotechnology companies. In April 2021, the NCBI announced the introduction of CovidArray, a microarray-based test, to detect COVID-19 markers N1 and N2 in nasopharyngeal swab samples. The universal microarray can detect the genotypes of six mutated bases related to COVID-19.

However, advancements in NGS technology, resulting in a cost-effective and accurate alternative to DNA microarray technology, are likely to hamper the market growth. In addition, factors such as the high cost associated with the microarray technology, stringent government regulations, standardization of data, and dearth of skilled professionals are also poised to impede market expansion in the coming years.

Type Insights

The oligonucleotide DNA microarrays segment held the largest share in 2022 and is anticipated to grow at a lucrative rate during the forecast period. The cost-effectiveness of the tool, with its higher capability to monitor the expression of every gene in the genome, and increased market penetration are driving the segment's growth. Moreover, these microarrays provide several benefits over other microarrays, such as providing controlled specificity of hybridization, making it the most prominent technique for analysis of single nucleotide polymorphisms, further escalating their demand in the projected period.

The complementary DNA microarrays segment is expected to register the fastest growth rate throughout the forecast period. The cDNA microarray is a powerful tool for studying gene expression in various organisms. Moreover, the increasing use of cDNA microarray in a wide range of applications such as polymorphism screening, genomic DNA clones mapping, and gene discoveries is further propelling segment growth.

Application Insights

The gene expression analysis segment dominated the market for DNA microarray in 2022. The segment growth is accounted for by the adoption of gene expression in different applications such as clinical diagnostics, drug discovery, microbiology, and others. In addition, the application of gene expression in various processes of drug discovery has increased exponentially in the past few years. Moreover, the advantages of DNA microarrays over other technologies and the leveraging scope of gene expression analysis have propelled the demand for this technology in different end-use applications.

However, the genotyping segment is expected to grow at a lucrative rate during the forecast period. The increasing R&D funding for precision medicine research, rising target disease prevalence, and strategic initiatives undertaken by the market players are anticipated to contribute to genotyping segment growth. For instance, in February 2021, 23andMe merged with VG Acquisition Corp. This merger would provide capital funds for their genetic consumer health business and genetic research activities.

End-user Insights

Based on the end-user segment, the market is segmented into hospitals & clinics, academic & research institutes, diagnostic centers, pharmaceutical & biotechnology companies, and others. The academic & research institutes segment held the largest revenue share in 2022, owing to the increasing adoption of microarrays in research and drug discovery applications. For instance, according to NIH, it was observed that DNA microarrays are utilized in the process of discovery of a drug used in cancer treatment.

On the other hand, diagnostic centers are likely to be the fastest-growing segment during the coming years. Diagnostic labs are projected to boost the demand for different products offered by leading companies that diagnose autoimmune diseases, cancers, infectious diseases, and other genetic mutation-related diseases. For instance, Applied Microarrays Inc. offers custom arrays to diagnose various infectious diseases and cancers. In addition, some other diseases diagnosed by these products include diet-related conditions like celiac, dysbiosis & general food intolerance.

Regional Insights

North America led the overall DNA microarray market due to the presence of leading market players in the region and rising investments by them in developing technologically advanced DNA microarray products. Moreover, technological advancements in genomics and access to modern research facilities are likely to create exponential growth opportunities for the players. Also, the high adoption of DNA microarray technology across research settings, from academic laboratories to biopharmaceutical companies, is further escalating the region’s growth.

Asia Pacific is expected to exhibit the fastest growth rate throughout the forecast period. The high prevalence of target diseases, surge in genomic research funding, and increasing awareness about genetic testing have bolstered the regional market. Moreover, increasing investments by local and international market players to develop novel DNA microarray products in the region is further anticipated to drive market growth in the coming years.

Key Companies & Market Share Insights

Key players are adopting new product development, merger & acquisition, and partnership strategies to increase their market share. Market players such as Illumina, Inc.; Agilent Technologies, Inc.; and Thermo Fisher Scientific, Inc., among others dominated the global DNA microarray market. These key players have been developing technologies for DNA microarray and providing products & services to different end-use applications. They have been introducing various innovations in the market and expanding their product portfolios to stay competitive. Some prominent players in the global DNA microarray market include:

• Thermo Fisher Scientific, Inc.

• QIAGEN

• Illumina, Inc.

• F. Hoffmann-La Roche Ltd.

• Agilent Technologies, Inc.

• Merck KGaA

• BIOMERIEUX

• PerkinElmer, Inc.

• Applied Micro Arrays

DNA Microarray Market Report Scope

Global DNA Microarray Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global DNA microarray market report based on the type, application, end-user, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Complementary DNA Microarrays

  • Oligonucleotide DNA Microarrays

  • Others

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Gene Expression Analysis

  • Genotyping

  • Others

• End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical and Biotechnology Companies

  • Diagnostic Centers

  • Hospitals and Clinics

  • Academic and Research Institute

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait